
Christina Lake Cannabis Corp. (CLCFF)
ValueMarkers Composite Index
DCF data not available
Christina Lake Cannabis Corp. (CLCFF) — VMCI valuation read
CLCFF prints VMCI 58/100 inside the Healthcare sector, where the median sits at 50. The 8-point above-median delta is the cleanest single-number summary of Christina Lake Cannabis Corp.'s composite stance, and in the mid-cap bucket it places the share ahead of the typical peer on the five-pillar mix.
On CLCFF, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.
**Investor frame.** CLCFF trades at 20.0x earnings, 11% above the Healthcare median of 18.0x; that is the value line. ROIC of 10.0% sits 0.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of 0.5x leaves covenant headroom; that is the risk line for Christina Lake Cannabis Corp. on the trailing financials.
CLCFF rose 0.5% over the trailing 7 days, with a -0.8% read on a 30-day basis.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.
- BXP.L - Beximco Pharmaceuticals Limited
- CSWYY - China Shineway Pharmaceutical Group Limited
- CSWYY - China Shineway Pharmaceutical Group Limited
- SHELTER.BO - Shelter Pharma Ltd.
- CRSTCHM.BO - Crestchem Limited
- SMD100.BK - SMD Rise Public Company Limited
- FCG.AX - Freedom Care Group Holdings Ltd.
- TWAPF - Towa Pharmaceutical Co., Ltd.